Association between SGLT2 Inhibitors and Risk of Dementia and Parkinson’s Disease: A Meta-Analysis of 12 Randomized Controlled Trials

By sjmartinez • July 9, 2024

Jaiswal V, Mashkoor Y, Raj N, Rajak K, Jaiswal A, Fonarow GC. Association between SGLT2 Inhibitors and Risk of Dementia and Parkinson's Disease: A Meta-Analysis of 12 Randomized Controlled Trials. Am J Med. 2024 Jul 6:S0002-9343(24)00420-0. doi: 10.1016/j.amjmed.2024.06.030. Epub ahead of print. PMID: 38977148.

Tags: Cardiology/Epi, Dementia, diabetes mellitus, heart failure, Parkinson’s disease, Publications, SGLT2I

Association of Mechanical Circulatory Support and Cardiac Catheterization Laboratory Procedural Volumes with Outcomes of Cardiogenic Shock

Tabibian K, Vadlakonda A, Coaston T, Sakowitz S, Ebrahimian S, Srivastava PK, Benharash P. Association of Mechanical Circulatory Support and Cardiac Catheterization Laboratory Procedural Volumes[...]

Reply: Keto CTA Study

Soto-Mota A, Norwitz NG, Manubolu VS, Kinninger A, Wood TR, Earls J, Feldman D, Budoff M. Reply: Keto CTA Study. JACC Adv. 2025 May 7;4(7):101862.[...]

Mild to moderate COPD, vitamin D deficiency, and longitudinal bone loss: The MESA study

Ghotbi E, Hathaway QA, Hadidchi R, Momtazmanesh S, Bancks MP, Bluemke DA, Barr RG, Post WS, Budoff M, Smith BM, Lima JAC, Demehri S. Mild[...]